Drug Discovery

Keeping the patient in mind is crucial for clinical research.

Can open source by applied to pharma R&D? This is the aim of Molecule.

A new computational tool could help improve the stability and predictability of ADCs.

With many cell and gene therapies skipping phase III trials entirely, academics must get to grips with GMP early.

Miguel Forte argues it’s time to fine tune the way we target solid tumors...

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."

How can wood be used to produce pharmaceutically relevant compounds?

A three-in-one approach to drug delivery combines different actives in a hydrogel-based delivery method.

Will unlocking the secrets of the microbiome yield a promising new horizon for medicine?

Industry experts share how their therapeutic products are shaping the future of the pharmaceutical landscape.